Ondansetron in pharma franchise in Himachal Pradesh

Ondansetron in PCD pharma franchise in Jaipur

Ondansetron in top pharma company in Nashik

Ondansetron in pcd pharma supplier in Guwahati

Ondansetron in phama franchise company in India
Ondansetron in phama distributor in Mangalore

Home/Products /ondansetron-8-mg-md-tablet

Ondotyle 8 MD Tablet

Composition : Ondansetron (8 mg) MD

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹951/-

Ondotyle 8 MD Tablet is a specialized medication that contains ondansetron as its active ingredient, formulated to provide effective relief from nausea and vomiting. Primarily prescribed for patients undergoing chemotherapy, radiation therapy, or surgical procedures, Ondotyle works by blocking the action of serotonin, a natural substance in the body that can trigger these unpleasant symptoms. This medication is particularly beneficial for those who may be sensitive to the side effects of cancer treatments or surgical interventions.

Ondotyle 8 MD Tablet is designed for rapid disintegration, making it easy to administer without the need for water. This feature is especially advantageous for individuals who may have difficulty swallowing pills, ensuring that relief is both accessible and efficient. The convenient format allows for on-the-go use, suitable for patients who may experience nausea in various settings.

The dosage of Ondotyle should be determined by a healthcare professional based on individual needs and specific circumstances. It is important to adhere to the prescribed regimen to maximize its effectiveness while minimizing potential side effects.

Read More

About the Product

Ondotyle 8 MD Tablet is a specialized medication that contains ondansetron as its active ingredient, formulated to provide effective relief from nausea and vomiting. Primarily prescribed for patients undergoing chemotherapy, radiation therapy, or surgical procedures, Ondotyle works by blocking the action of serotonin, a natural substance in the body that can trigger these unpleasant symptoms. This medication is particularly beneficial for those who may be sensitive to the side effects of cancer treatments or surgical interventions.

Ondotyle 8 MD Tablet is designed for rapid disintegration, making it easy to administer without the need for water. This feature is especially advantageous for individuals who may have difficulty swallowing pills, ensuring that relief is both accessible and efficient. The convenient format allows for on-the-go use, suitable for patients who may experience nausea in various settings.

The dosage of Ondotyle should be determined by a healthcare professional based on individual needs and specific circumstances. It is important to adhere to the prescribed regimen to maximize its effectiveness while minimizing potential side effects.

Common side effects may include headache, dizziness, constipation, and fatigue. Serious side effects are rare but can include allergic reactions.

Ondotyle 8 MD Tablet is indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery.

Always consult a healthcare professional before starting any new medication, and inform them of any existing health conditions or other medications being taken to avoid potential interactions.

Store in a cool, dry place away from direct sunlight, and keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation